Skip to main content

Clinical characteristics and variant spectrum of NF1 in Chinese patients with neurofibromatosis type 1: a cross-sectional study

In brief

Chinese NF1 study identifies 45 previously unreported gene variants

In a cross-sectional cohort of 847 Chinese patients, café-au-lait spots were seen in 98%, neurofibromas in 71% and plexiform neurofibromas in 21%. Sequencing of 211 patients found 152 distinct NF1 variants, including 45 not previously reported; the study maps clinical and genetic features, but longitudinal research is needed to establish clinically meaningful links between variants and disease severity.

Journal
Orphanet journal of rare diseases (Q1)
Published
17 August 2026
Study design
Cross-sectional study
Evidence level
Level 3, Low (CEBM 3b)
Authors
Ya-Xin Guo, Xin-De Liu, Yi-Qiu Yan, He-Xiao Wang, Xiao-Shi Yang, Yuan Lv, et al.
PMID
43015836
DOI
10.1186/s13023-026-04534-9

Why clinicians should know about it

  • Picked for Genetics (clinical) (top studies of the week, 15 November 2026): Large NF1 cohort characterizes clinical features and pathogenic variant spectrum

Abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is a rare autosomal dominant multisystem disorder caused by NF1 gene variants. Although NF1 shows marked clinical and genetic heterogeneity, large Chinese cohorts integrating clinical features, NF1 variant spectrum, and external variant contextualization remain limited. METHODS: We conducted a cross-sectional study of 847 clinically confirmed Chinese patients with NF1 to characterize demographic features, clinical manifestations, DNB-defined severity, and NF1 variant spectrum. Whole-exome sequencing was performed in 211 patients. Transcript-level variant distribution was assessed using a 500-bp sliding-window approach and further contextualized using ClinVar-derived NF1 variant data. RESULTS: Among 847 patients, the median age was 23 years, 27.5% had a family history of NF1, and more than 90% were younger than 40 years. Café-au-lait macules, neurofibromas, and plexiform neurofibromas were observed in 98.3%, 70.7%, and 20.9% of patients, respectively. Younger age, lower neurofibroma burden, and absence of learning difficulties were associated with DNB-defined mild classification. Among 211 genetically tested patients, pathogenic/likely pathogenic NF1 variants were identified in 182 patients, 11 carried NF1 variants of uncertain significance, and 18 had no reportable NF1 variant. In total, 152 distinct NF1 variants were identified, including 45 novel sites. Transcript-level analysis showed regional variation in reportable nucleotide-level NF1 variants, with relatively higher variant density around exons 10-15 and 44-49. Comparison with ClinVar pathogenic/likely pathogenic NF1 variants showed no significant window-level difference after multiple-testing correction. CONCLUSIONS: This cross-sectional study summarizes the clinical and genetic features of Chinese patients with NF1 and expands the known NF1 variant spectrum in this population. Transcript-level analysis showed regional variation in reportable NF1 variants, broadly paralleling the ClinVar pathogenic/likely pathogenic NF1 variant distribution. These findings provide a basis for future longitudinal studies to validate clinically meaningful genotype-phenotype relationships in NF1.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.